Ascendis Pharma to Report Third Quarter 2025 Financial Results and Provide Business Update on November 12, 2025

Core Insights - Ascendis Pharma A/S plans to report its third quarter 2025 financial results and provide a business update on November 12, 2025, after U.S. market close [1] - A conference call and live webcast will be held on the same day at 4:30 p.m. Eastern Time to discuss the financial results [1][2] Company Overview - Ascendis Pharma is a global biopharmaceutical company focused on its innovative TransCon technology platform to address unmet medical needs [3] - The company is headquartered in Copenhagen, Denmark, with additional facilities in Europe and the United States [3]